CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
High ImpactOriginal article

Curium buys radiopharma rival Lantheus for $8B; Sandoz settles price-fixing case

Positive
AI Analysis

Summary

Curium announced an $8 billion acquisition of radiopharma company Lantheus at $102.5 per share, with potential earn-out payments of up to $12 per share. Sandoz settled a price-fixing case.

Importance:8/10
Sentiment:
0.30
M&Aradiopharmaacquisitionprice-fixing settlement
Related Companies

Read the original article

Published by Endpoints News on August 3, 2026 2:28 PM

Read Original